This case illustrates different growth strategies in the pharmaceutical business. Is management R&D a crucial element of growth strategies, the case illustrates the value of using a holistic framework for R&D when enlarging the firm's company footprint.
Zoetis, Pfizer’s Animal Health Spin-Off (B) Harvard Case Solution & Analysis
The case serves the intent of identifying the steps that are crucial for the performance of these strategies, and comparing organic and inorganic growth strategies.
PUBLICATION DATE: August 21, 2015 PRODUCT #: IN1092-HCB-ENG
This is just an excerpt. This case is about LEADERSHIP & MANAGING PEOPLE
Related Case Solutions & Analyses:
Lotus Development Corp.: Spousal Equivalents (A)
Getting the Right Payoff From Customer Penalty Fees
LinkedIn: Transformation Driven From Within
Spontaneous Virtual Teams: Improving Organizational Performance Through Information and Communication Technology
Saving Customers at Vigil Home Security
The Future of Same-Day Delivery: Same as the Past?
Coaching High Performance: Lessons from Veterans in Two Arenas
Gillette Company (E): Procter & Gamble
Lean Methodology: Selecting and Executing a Personal 5S Application Project
Big Spaceship: The Evolving Agency
